Literature DB >> 32610070

Turning Cold into Hot: Firing up the Tumor Microenvironment.

Qianqian Duan1, Hualing Zhang2, Junnian Zheng3, Lianjun Zhang4.   

Abstract

Cancers develop within complex tissue environments consisting of diverse innate and adaptive immune cells, along with stromal cells, vascular networks, and many other cellular and noncellular components. The high heterogeneity within the tumor microenvironment (TME) remains a key obstacle in understanding and treating cancer. Understanding the dynamic functional interplay within this intricate ecosystem will provide important insights into the design of effective combinatorial strategies against cancer. Here, we present recent technical advances to explore the complexity of the TME. Then, we discuss how innate immune sensing machinery, genetic alterations of oncogenic signaling, cellular metabolism, and epigenetic factors are involved in modulating the TME. Finally, we summarize the potential strategies to boost antitumor immunity by therapeutically exploiting the TME.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  epigenetic; immune checkpoint blockade; metabolism; single cell profiling; tumor microenvironment

Mesh:

Substances:

Year:  2020        PMID: 32610070     DOI: 10.1016/j.trecan.2020.02.022

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  163 in total

Review 1.  Roles of long noncoding RNAs on tumor immune escape by regulating immune cells differentiation and function.

Authors:  Lisha Chang; Juan Li; Jie Ding; Yifan Lian; Chaonan Huangfu; Keming Wang
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

2.  Liposomal Delivery of Mitoxantrone and a Cholesteryl Indoximod Prodrug Provides Effective Chemo-immunotherapy in Multiple Solid Tumors.

Authors:  Kuo-Ching Mei; Yu-Pei Liao; Jinhong Jiang; Michelle Chiang; Mercedeh Khazaieli; Xiangsheng Liu; Xiang Wang; Qi Liu; Chong Hyun Chang; Xiao Zhang; Juan Li; Ying Ji; Brenda Melano; Donatello Telesca; Tian Xia; Huan Meng; Andre E Nel
Journal:  ACS Nano       Date:  2020-09-25       Impact factor: 15.881

Review 3.  Peptides that immunoactivate the tumor microenvironment.

Authors:  Natsuki Furukawa; Aleksander S Popel
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-12-01       Impact factor: 10.680

Review 4.  Targeting the extracellular matrix for immunomodulation: applications in drug delivery and cell therapies.

Authors:  Samira Aghlara-Fotovat; Amanda Nash; Boram Kim; Robert Krencik; Omid Veiseh
Journal:  Drug Deliv Transl Res       Date:  2021-06-26       Impact factor: 4.617

Review 5.  The immune landscape of common CNS malignancies: implications for immunotherapy.

Authors:  Martina Ott; Robert M Prins; Amy B Heimberger
Journal:  Nat Rev Clin Oncol       Date:  2021-06-11       Impact factor: 66.675

Review 6.  Overcoming biological barriers to improve solid tumor immunotherapy.

Authors:  Anvay Ukidve; Katharina Cu; Ninad Kumbhojkar; Joerg Lahann; Samir Mitragotri
Journal:  Drug Deliv Transl Res       Date:  2021-02-20       Impact factor: 4.617

Review 7.  Stromal Cells Underlining the Paths From Autoimmunity, Inflammation to Cancer With Roles Beyond Structural and Nutritional Support.

Authors:  Amanda M Honan; Zhibin Chen
Journal:  Front Cell Dev Biol       Date:  2021-05-25

Review 8.  Hijacked Immune Cells in the Tumor Microenvironment: Molecular Mechanisms of Immunosuppression and Cues to Improve T Cell-Based Immunotherapy of Solid Tumors.

Authors:  Emre Balta; Guido H Wabnitz; Yvonne Samstag
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

9.  On-treatment immune prognostic score for patients with relapsed and/or metastatic head and neck squamous cell carcinoma treated with immunotherapy.

Authors:  Pablo Nenclares; Lucinda Gunn; Heba Soliman; Mateo Bover; Amy Trinh; Isla Leslie; Kee Howe Wong; Alan Melcher; Kate Newbold; Chris M Nutting; Derfel Ap Dafydd; Shreerang A Bhide; Kevin Harrington
Journal:  J Immunother Cancer       Date:  2021-06       Impact factor: 13.751

10.  Magnetism-mediated targeting hyperthermia-immunotherapy in "cold" tumor with CSF1R inhibitor.

Authors:  Yuefei Fang; Yang He; Canhao Wu; Meng Zhang; Zeyun Gu; Jiaxin Zhang; Ergang Liu; Qin Xu; Akmal M Asrorov; Yongzhuo Huang
Journal:  Theranostics       Date:  2021-05-03       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.